Mark A. Thierer
Chairman and Chief Executive Officer
Mark Thierer is Chairman and Chief Executive Officer of Catamaran (NASDAQ: CTRX, TSX: CCT), one of the nation’s largest pharmacy benefit managers serving more than 25 million members. Mr. Thierer has been instrumental in redefining the way pharmacy benefits are managed by successfully merging two industry-leading PBMs — SXC Health Solutions and Catalyst Health Solutions — to create Catamaran, a $10 billion company scaled to drive significant client savings, with a service offering wrapped in flexibility, agility and a client-centered philosophy. Through his leadership, Catamaran has emerged as the leading alternative to the traditional approach of other PBMs, with customized solutions that benefit healthcare payers and the communities they serve.
As a 30-year healthcare industry leader, Mr. Thierer has a track record of leading organizations to financial and operational success. He joined SXC in 2006 as President and Chief Operating Officer and was named President and CEO in 2008, and CEO and Chairman of the Board in 2011. From the beginning, his vision was to transform SXC from a pure technology player to an industry leading full service provider. When Mr. Thierer joined SXC, revenues were $50 million, EBITDA was $12 million annually, and the company market capitalization was $160 million. Since that time the company has posted a compound annual growth rate of 50% and an amazing fifty-fold increase in shareholder value. This growth and value creation earned the company numerous industry awards, with Fortune naming SXC the #1 Fastest Growing Company in 2011.
Prior to joining SXC, Mr. Thierer led the evolution of Physicians Interactive, a division of Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), the leading provider of Electronic Health Records, ePrescribing and IT solutions for physicians. As President, he repositioned the company from a supplier of electronic detailing to a full-service provider of online marketing and educational tools for physicians.
Mr. Thierer also spent 10 years with CaremarkRx, now CVS Caremark Corporation (NYSE:CVS), as a corporate officer and key executive in growing the company into a market-leading PBM and specialty pharmacy company. As Senior Vice President, Industry Relations, he built executive-level supply chain relationships with pharmaceutical, biotech and generic drug companies and established Caremark’s contracting relationships with major chain drug stores such as Walgreens, CVS, Wal-Mart and Rite Aid. Prior to Caremark, he spent 10 years at IBM where he held positions of increasing responsibility in sales management in the company’s health industry vertical.
Mr. Thierer is dedicated to helping professional organizations improve efficiency and effectiveness in the pharmaceutical industry. He serves as the incoming Chairman of the Board of Directors of the Pharmaceutical Care Management Association (PCMA) and maintains active memberships in the National Council for Prescription Drug Programs (NCPDP), Academy of Managed Care Pharmacy (AMCP), National Association of Chain Drug Stores (NACDS), and the Healthcare Information and Management Systems Society (HIMSS). Committed to improving his community, he also serves on the Board of the Museum of Science and Industry and the Lyric Opera of Chicago. He is active in the Economic Club, serves on board of the Executive’s Club of Chicago and CEOs Against Cancer.
Mr. Thierer holds a Bachelor of Science degree in Finance from the University of Minnesota, an M.B.A from Nova Southern University, and has earned the Certified Employee Benefits Specialist (CEBS) designation. He is also a frequent guest lecturer at Northwestern Kellogg School of Management and The Wharton School of the University of Pennsylvania.
Executive Vice President & Chief Financial Officer
Jeff Park is Executive Vice President and Chief Financial Officer at Catamaran (NASDAQ: CTRX, TSX: CCT) the nation’s fourth-largest pharmacy benefits manager (PBM) serving more than 25 million members. Responsible for acquisitions, investor relations and financial operations, Mr. Park is driving shareholder value for the $13 billion company and establishing it as a leader in delivering prescription drug cost savings to clients and consumers through its expanded leverage across the pharmaceutical supply chain.
Mr. Park was instrumental in the creation of Catamaran, the successful merger of two industry-leading PBMs — SXC Health Solutions and Catalyst Health Solutions. Joining SXC Health Solutions’ Board of Directors in 2003, Mr. Park became the company’s Chief Financial Officer in 2006. As CFO, he led the company through a successful initial public offering on NASDAQ that raised $38 million and expanded its visibility among industry analysts and thought leaders. Between 2006 and 2011, Mr. Park guided SXC through five strategic acquisitions, which helped grow revenues from $50 million to $5 billion, and profit from $12 million to $175 million. SXC’s growth trajectory earned it the number-one position on the FORTUNE “100 Fastest-Growing Companies” list in 2011.
Prior to joining SXC, Mr. Park was a portfolio manager at venture capital firm Covington Capital, supporting more than $600 million in assets. In this role, Mr. Park sourced and selected high-growth businesses in a wide range of industries including technology, telecommunication services, media and healthcare. During his tenure, Mr. Park completed approximately 40 transactions, supporting dozens of investee companies and representing Covington as a member of their Boards of Directors. Mr. Park’s role at Covington also included representing Covington to the shareholders and mutual fund advisors of the Toronto Stock Exchange listed funds. SXC was an investee company of Covington at the time he joined the company.
Prior roles include Manager of Audit Services within Deloitte’s Audit and Assurance Services practice and Senior Financial Analyst at IBM, where he was responsible for financial underwriting and proposals for some of the largest clients and prospects of the Canadian global services operations.
Mr. Park is currently on the Board of Directors of the Ray Graham Association, a not-for-profit organization supporting more than 1,200 disabled individuals and their families in their goal to lead full and independent lives.
Mr. Park graduated on the Dean’s honors list from Brock University in 1995 with a Bachelor of Science in accounting.
Executive Vice President of Research and Innovation
John Romza is Executive Vice President of Research and Innovation at Catamaran (NASDAQ: CTRX, TSX: CCT), the nation’s fourth largest pharmacy benefits manager (PBM) serving more than 25 million members. Through Catamaran’s Office of Innovation, Mr. Romza and his team create inventive new products and services to effectively manage healthcare costs through a focus on prescription drug therapy as one of the earliest and most cost-effective preventive treatments on the road to health.
Mr. Romza was a key member of the leadership team that formed Catamaran, merging two industry-leading PBMs — SXC Health Solutions and Catalyst Health Solutions — to create a new entity with large-scale purchasing power wrapped in flexibility, agility and a client-centered philosophy. As one of the industry’s most esteemed and tenured PBM experts, Mr. Romza led the development of SXC’s technology footprint for nearly 30 years, most recently as Chief Technology Officer, to which he was appointed in 2002.
Mr. Romza has deep experience in both leading large-scale software development projects and spearheading consulting and training engagements in information management for the pharmacy industry. Recent highlights include IntegrailRx, a real-time risk assessment tool that uses pharmacy claims data to improve healthcare by enabling early intervention and an enhanced Coordination of Benefits (COB) service — a real-time point-of-sale approach to coordinating pharmacy benefits with multiple payers. Mr. Romza and his team are also actively working on a next-generation suite of solutions that will shape the delivery of healthcare, including patient-centered medical home pharmacy solutions, pharmacy and medical data integration, mobile app development, medical therapy management and the use of health information exchanges to streamline the sharing of health information among providers.
As a recognized expert in the field, he is often quoted in industry publications and is a contributing author to the AMCP publication “Managed Care Pharmacy Practice,” a commonly used textbook in schools of pharmacy throughout the United States. He has also presented at NCPDP educational forums.
Romza received a Bachelor of Science degree from Loyola University of Chicago, where he also taught computer science and mathematics courses. He also earned a Master of Science degree from the Illinois Institute of Technology. He is actively involved in several associations including the National Council of Prescription Drug Programs (NCPDP) and the American Society for Automation in Pharmacy (ASAP).
Senior Vice President, General Counsel and Corporate Secretary
Cliff Berman is Senior Vice President, General Counsel and Corporate Secretary of Catamaran (NASDAQ: CTRX, TSX: CCT) the nation’s fourth largest pharmacy benefits manager (PBM) serving more than 25 million members. As a key member of Catamaran’s leadership team, Mr. Berman is responsible for facilitating the company’s business goals and profitability by mitigating legal and operational risk to maintain its position as a leader in delivering prescription drug cost savings to clients and consumers through its expanded leverage across the pharmaceutical supply chain.
Mr. Berman was instrumental in the creation of Catamaran, the successful merger of two industry-leading PBMs — SXC Health Solutions and Catalyst Health Solutions, joining SXC in 2008 with a wealth of experience in the pharmacy and PBM space. Prior to this, he served as Division Counsel, Legal Regulatory and Compliance for Abbott Laboratories, where he worked for more than five years. Prior to Abbott, Mr. Berman worked at Allscripts Healthcare Solutions, where he served as SVP, General Counsel and Chief Privacy Officer. Earlier in his career, he also held a number of positions over an eight-year period with Caremark Inc., including Vice President, Legal Services.
Mr. Berman received his Bachelor of Science in pharmacy from the University of Michigan, his J.D. from Loyola University, and his MBA from the University of Chicago. He served on the Illinois State Board of Pharmacy from 1994–1999. Mr. Berman is also a past president of the Pharmaceutical Care Management Association.
Executive Vice President, Pharmacy Operations
Joel Saban is Executive Vice President of Pharmacy Operations at Catamaran (NASDAQ: CTRX, TSX: CCT), the nation’s fourth largest pharmacy benefits manager (PBM) serving more than 25 million members. With its comprehensive suite of best-in-class services and solutions, Catamaran delivers stronger purchasing power and an industry-leading offering in generics, mail, retail and specialty pharmacy, under Mr. Saban’s operational expertise.
Mr. Saban was a key member of the leadership team that formed Catamaran, merging two industry-leading PBMs — SXC Health Solutions and Catalyst Health Solutions — to create a new entity that delivers flexible, customizable solutions that reduce costs and manage complexity. At Catamaran, Mr. Saban is responsible for the operations of the mail order and specialty pharmacies, in addition to all cost-of-goods contracting and vendor relations.
Prior to joining SXC in 2010, Mr. Saban was Senior Vice President of Industry Relations at CVS Caremark, responsible for directing brand pharmaceutical industry relations, including contract negotiations and administration, financial analysis, and strategic business development. His role also included evaluating opportunities, analyzing contract profitability and ensuring that contracts met company business objectives in the pharmaceutical and retail areas. Prior to this, Mr. Saban served as Director of Medical and Scientific Affairs for the Alzheimer’s Association.
Mr. Saban is a member of the Academy of Managed Care Pharmacy and the Pharmaceutical Care Management Association. He earned a Bachelor of Science degree in biology from the University of Illinois Champaign-Urbana and received his Master of Science in pharmacology and molecular biology from the Chicago Medical School in North Chicago, Illinois.